Suppr超能文献

医学上重要的蚊媒黄病毒中抗体交叉反应的程度:一项系统综述。

Magnitude of Antibody Cross-Reactivity in Medically Important Mosquito-Borne Flaviviruses: A Systematic Review.

作者信息

Endale Adugna, Medhin Girmay, Darfiro Koyamo, Kebede Nigatu, Legesse Mengistu

机构信息

Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.

School of Medicine, College of Medicine and Health Sciences, Dire Dawa University, Dire Dawa, Ethiopia.

出版信息

Infect Drug Resist. 2021 Oct 19;14:4291-4299. doi: 10.2147/IDR.S336351. eCollection 2021.

Abstract

INTRODUCTION

Flaviviruses are a genus of enveloped single-stranded RNA viruses that include dengue virus (DENV), yellow fever virus, West Nile virus (WNV), Japanese encephalitis virus, and Zika virus. Nowadays, diverse serological assays are available to diagnose flaviviruses. However, infection with flaviviruses induces cross-reactive antibodies, which are a challenge for serological diagnosis.

OBJECTIVE

This systematic review aimed to assess the magnitude of medically important mosquito-borne flavivirus-induced antibody cross-reactivity and its influence on serological test outcomes.

METHODS

This study was designed based on the PRISMA guidelines. It includes original research articles published between 1994 and 2019 that reported serological cross-reactions between medically important mosquito-borne flaviviruses. Articles were searched on PubMed using controlled vocabulary. Eligibility was assessed by title, abstract, and finally by reading the full paper. The articles included are compared, evaluated, and summarized narratively.

RESULTS

A total of 2,911 articles were identified, and finally 14 were included. About 15.4%-84% of antibodies produced against non-DENV flaviviruses were cross-reactive with DENV on different assays. Up to 30% IgM and up to 60% IgG antibodies produced against non-WNV flaviviruses were cross-reactive with WNV on EIA assays. The magnitude of antibodies produced against flaviviruses that are cross-reactive with chikungunya virus () was minimal (only about 7%). The highest antibody cross-reactivity of flaviviruses was reported in IgG-based assays compared to IgM-based assays and assays based on E-specific immunoglobulin compared to NS1-specific immunoglobulin. It was found that preexisting immunity due to vaccination or prior flavivirus exposure to antigenetically related species enhanced the cross-reactive antibody titer.

CONCLUSION

This review found the highest cross-reaction between DENV and non-DENV flaviviruses, especially yellow fever virus, and the least between chikungunya virus and DENV. Moreover, cross-reaction was higher on IgG assays than IgM ones and assays based on Eprotein compared to NS1protein. This implies that the reliability of serological test results in areas where more than one flavivirus exists is questionable. Therefore, interpretation of the existing serological assays should be undertaken with a great caution. Furthermore, research on novel diagnostic signatures for differential diagnosis of flaviviruses is needed.

摘要

引言

黄病毒属是一类包膜单链RNA病毒,包括登革病毒(DENV)、黄热病毒、西尼罗河病毒(WNV)、日本脑炎病毒和寨卡病毒。如今,有多种血清学检测方法可用于诊断黄病毒。然而,感染黄病毒会诱导产生交叉反应抗体,这对血清学诊断构成了挑战。

目的

本系统评价旨在评估医学上重要的蚊媒黄病毒诱导的抗体交叉反应程度及其对血清学检测结果的影响。

方法

本研究基于PRISMA指南设计。纳入1994年至2019年间发表的报告医学上重要的蚊媒黄病毒之间血清学交叉反应的原创研究文章。使用控制词汇在PubMed上搜索文章。通过标题、摘要,最后阅读全文来评估文章的 eligibility。对纳入的文章进行比较、评估并进行叙述性总结。

结果

共识别出2911篇文章,最终纳入14篇。在不同检测方法中,针对非DENV黄病毒产生的抗体中,约15.4%-84%与DENV发生交叉反应。在酶免疫分析(EIA)中,针对非WNV黄病毒产生的IgM抗体中高达30%、IgG抗体中高达60%与WNV发生交叉反应。针对与基孔肯雅病毒交叉反应的黄病毒产生的抗体量极少(仅约7%)。与基于IgM的检测方法以及基于E特异性免疫球蛋白的检测方法相比,基于NS1特异性免疫球蛋白的检测方法,基于IgG的检测方法报告的黄病毒抗体交叉反应性最高。研究发现,由于接种疫苗或先前接触过与抗原相关的黄病毒而产生的预先存在的免疫力会提高交叉反应抗体滴度。

结论

本综述发现DENV与非DENV黄病毒之间的交叉反应最高,尤其是与黄热病毒,而基孔肯雅病毒与DENV之间的交叉反应最少。此外,IgG检测方法的交叉反应高于IgM检测方法,基于E蛋白的检测方法的交叉反应高于基于NS1蛋白的检测方法。这意味着在存在多种黄病毒的地区,血清学检测结果的可靠性值得怀疑。因此,对现有血清学检测方法的解读应格外谨慎。此外,需要开展关于黄病毒鉴别诊断的新型诊断标志物的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf77/8541746/2ea433dd45e0/IDR-14-4291-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验